Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

US Patent 9169220 · Granted Oct 27, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Capsazepine analogs for the treatment of cancer and other proliferative diseases2025
Inhibition of Olig2 activity2024
Inhibition of Olig2 activity2024
Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase 2024
Antibiotic ammonium compounds and methods for the treatment of bacterial infecti2024
Inhibition of Olig2 activity2023
Inhibition of Olig2 activity2023
Inhibition of Olig2 activity2023
Inhibition of Olig2 activity2023
Redox substrates for leukocyte esterase2022
Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase 2022
Methods and compositions for the treatment of Shiga Toxicosis2022